463 related articles for article (PubMed ID: 27842666)
1. Simplified response monitoring criteria for multiple myeloma in patients undergoing therapy with novel agents using computed tomography.
Schabel C; Horger M; Kum S; Weisel K; Fritz J; Ioanoviciu SD; Bier G
Eur J Radiol; 2016 Dec; 85(12):2195-2199. PubMed ID: 27842666
[TBL] [Abstract][Full Text] [Related]
2. Whole-Body Low-Dose CT in Multiple Myeloma: Diagnostic Value of Appendicular Medullary Patterns of Attenuation.
Koutoulidis V; Terpos E; Klapa I; Cheliotis G; Ntanasis-Stathopoulos I; Boultadaki A; Gavriatopoulou M; Kastritis E; Dimopoulos MA; Moulopoulos LA
AJR Am J Roentgenol; 2021 Mar; 216(3):742-751. PubMed ID: 33439048
[No Abstract] [Full Text] [Related]
3. A longitudinal computed tomography study of lenalidomide and bortezomib treatment for multiple myeloma: trabecular microarchitecture and biomechanics assessed using multidetector computed tomography.
Takasu M; Tani C; Kaichi Y; Sakoda Y; Kiguchi M; Date S; Kuroda Y; Sakai A; Awai K
Clin Lymphoma Myeloma Leuk; 2014 Dec; 14(6):485-92. PubMed ID: 25190250
[TBL] [Abstract][Full Text] [Related]
4. Can whole-body low-dose multidetector CT exclude the presence of myeloma bone disease in patients with monoclonal gammopathy of undetermined significance (MGUS)?
Spira D; Weisel K; Brodoefel H; Schulze M; Kaufmann S; Horger M
Acad Radiol; 2012 Jan; 19(1):89-94. PubMed ID: 22142681
[TBL] [Abstract][Full Text] [Related]
5. Improved Follow-Up and Response Monitoring of Thoracic Cage Involvement in Multiple Myeloma Using a Novel CT Postprocessing Software: The Lessons We Learned.
Bier G; Mustafa DF; Kloth C; Weisel K; Ditt H; Nikolaou K; Horger M
AJR Am J Roentgenol; 2016 Jan; 206(1):57-63. PubMed ID: 26700335
[TBL] [Abstract][Full Text] [Related]
6. The benefit of using whole-body, low-dose, nonenhanced, multidetector computed tomography for follow-up and therapy response monitoring in patients with multiple myeloma.
Horger M; Kanz L; Denecke B; Vonthein R; Pereira P; Claussen CD; Driessen C
Cancer; 2007 Apr; 109(8):1617-26. PubMed ID: 17330855
[TBL] [Abstract][Full Text] [Related]
7. Increasing bone sclerosis during bortezomib therapy in multiple myeloma patients: results of a reduced-dose whole-body MDCT study.
Schulze M; Weisel K; Grandjean C; Oehrlein K; Zago M; Spira D; Horger M
AJR Am J Roentgenol; 2014 Jan; 202(1):170-9. PubMed ID: 24370141
[TBL] [Abstract][Full Text] [Related]
8. Diffusion-weighted whole-body MRI for evaluation of early response in multiple myeloma.
Lacognata C; Crimì F; Guolo A; Varin C; De March E; Vio S; Ponzoni A; Barilà G; Lico A; Branca A; De Biasi E; Gherlinzoni F; Scapin V; Bissoli E; Berno T; Zambello R
Clin Radiol; 2017 Oct; 72(10):850-857. PubMed ID: 28587715
[TBL] [Abstract][Full Text] [Related]
9. Comparison of qualitative and quantitative CT and MRI parameters for monitoring of longitudinal spine involvement in patients with multiple myeloma.
Horger M; Fritz J; Thaiss WM; Ditt H; Weisel K; Haap M; Kloth C
Skeletal Radiol; 2018 Mar; 47(3):351-361. PubMed ID: 29222688
[TBL] [Abstract][Full Text] [Related]
10. Whole-body diffusion-weighted MRI for evaluation of response in multiple myeloma patients following bortezomib-based therapy: A large single-center cohort study.
Zhang Y; Xiong X; Fu Z; Dai H; Yao F; Liu D; Deng S; Hu C
Eur J Radiol; 2019 Nov; 120():108695. PubMed ID: 31589995
[TBL] [Abstract][Full Text] [Related]
11. Whole-body low-dose CT recognizes two distinct patterns of lytic lesions in multiple myeloma patients with different disease metabolism at PET/MRI.
Zambello R; Crimì F; Lico A; Barilà G; Branca A; Guolo A; Varin C; Vezzaro R; Checuz L; Scapin V; Berno T; Pizzi M; Ponzoni A; De Biasi E; Vio S; Semenzato G; Zucchetta P; Lacognata C
Ann Hematol; 2019 Mar; 98(3):679-689. PubMed ID: 30539276
[TBL] [Abstract][Full Text] [Related]
12. Whole-body diffusion-weighted MRI with apparent diffusion coefficient mapping for early response monitoring in multiple myeloma: preliminary results.
Horger M; Weisel K; Horger W; Mroue A; Fenchel M; Lichy M
AJR Am J Roentgenol; 2011 Jun; 196(6):W790-5. PubMed ID: 21606271
[TBL] [Abstract][Full Text] [Related]
13. Patients with multiple myeloma treated with thalidomide: evaluation of clinical parameters, cytokines,angiogenic markers, mast cells and marrow CD57+ cytotoxic T cells as predictors of outcome.
Mileshkin L; Honemann D; Gambell P; Trivett M; Hayakawa Y; Smyth M; Beshay V; Ritchie D; Simmons P; Milner AD; Zeldis JB; Prince HM
Haematologica; 2007 Aug; 92(8):1075-82. PubMed ID: 17640854
[TBL] [Abstract][Full Text] [Related]
14. CT imaging of bone and bone marrow infiltration in malignant melanoma--Challenges and limitations for clinical staging in comparison to 18FDG-PET/CT.
Bier G; Hoffmann V; Kloth C; Othman AE; Eigentler T; Garbe C; La Fougère C; Pfannenberg C; Nikolaou K; Klumpp B
Eur J Radiol; 2016 Apr; 85(4):732-8. PubMed ID: 26971416
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic value of whole-body low-dose computed tomography (WBLDCT) in bone lesions detection in patients with multiple myeloma (MM).
Ippolito D; Besostri V; Bonaffini PA; Rossini F; Di Lelio A; Sironi S
Eur J Radiol; 2013 Dec; 82(12):2322-7. PubMed ID: 24074647
[TBL] [Abstract][Full Text] [Related]
16. Automated "Bone Subtraction" Image Analysis Software Package for Improved and Faster CT Monitoring of Longitudinal Spine Involvement in Patients with Multiple Myeloma.
Horger M; Ditt H; Liao S; Weisel K; Fritz J; Thaiss WM; Kaufmann S; Nikolaou K; Kloth C
Acad Radiol; 2017 May; 24(5):623-632. PubMed ID: 28256439
[TBL] [Abstract][Full Text] [Related]
17. Hyperattenuating bone marrow abnormalities in myeloma patients using whole-body non-enhanced low-dose MDCT: correlation with haematological parameters.
Horger M; Pereira P; Claussen CD; Kanz L; Vonthein R; Denecke B; Driessen C
Br J Radiol; 2008 May; 81(965):386-96. PubMed ID: 18440943
[TBL] [Abstract][Full Text] [Related]
18. Bone formation following lenalidomide-dexamethasone combination therapy in cases of multiple myeloma refractory to high-dose chemotherapy with bortezomib and autologous peripheral blood stem cell transplantation: report of a case and review of the literature.
Sekiguchi Y; Ichikawa K; Wakabayashi M; Sugimoto K; Tomita S; Izumi H; Nakamura N; Sawada T; Ohta Y; Komatsu N; Noguchi M
Int J Clin Exp Pathol; 2015; 8(8):9609-19. PubMed ID: 26464727
[TBL] [Abstract][Full Text] [Related]
19. [Bone disease in multiple myeloma. A study of 237 cases].
Scutellari PN; Orzincolo C; Bagni B; Feggi L; Franceschini F; Spanedda R
Radiol Med; 1992 May; 83(5):542-60. PubMed ID: 1631329
[TBL] [Abstract][Full Text] [Related]
20. Role of dynamic contrast-enhanced sonography for characterization and monitoring of extramedullary myeloma: comparison with serologic data.
Pintoffl JP; Weisel K; Schulze M; Maksimovic O; Claussen CD; Kramer U; Horger M
J Ultrasound Med; 2013 Oct; 32(10):1777-88. PubMed ID: 24065259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
